Personalized drug testing in a patient with non-small-cell lung cancer using cultured cancer cells from pleural effusion

OBJECTIVE: Patients with non-small-cell lung cancer (NSCLC) and primary or acquired resistance do not respond to targeted drugs. We explored whether cancer cells can be cultured from liquid biopsies from patients with primary resistance to tyrosine kinase inhibitors (TKIs). We aimed to predict patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Ming, Hong, Guodai, Chen, Yu, Ye, Lina, Zhang, Kang, Cai, Kaihong, Yang, Huadong, Long, Xiang, Gao, Wenbin, Li, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Prospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509736/
https://www.ncbi.nlm.nih.gov/pubmed/32954884
http://dx.doi.org/10.1177/0300060520955058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509736/
https://www.ncbi.nlm.nih.gov/pubmed/32954884
http://dx.doi.org/10.1177/0300060520955058

Ejemplares similares